StockData

Burning Rock Biotech vs Concord Medical Services

BNR and CCM side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BNR and CCM compare

Concord Medical Services grew revenue faster over the last twelve months (19.9% versus 4.6% for Burning Rock Biotech).

Burning Rock Biotech keeps more of each dollar of sales as profit, with a net margin of −10.3% compared with −20.2% at Concord Medical Services.

Burning Rock Biotech scores higher on the StockData Score (4 against 3 for Concord Medical Services), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBNRCCM
Size and price
Share price$12.50$3.72
Change, 1 year6.5%−20.0%
Change, 5 years−90.9%−84.2%
Beta (5Y)2.521.13
Employees667610
StockData Score
Total score4 (better)3
Valuation score00
Growth score12 (better)
Performance score11
Health score2 (better)0
Dividend score00
Growth
Revenue growth (TTM)4.6%19.9% (better)
Revenue growth, 5Y average4.6%15.6% (better)
Profitability
Gross margin74.7% (better)5.6%
Operating margin−10.2% (better)−56.8%
Net margin−10.3% (better)−20.2%
FCF margin−6.2% (better)−56.1%
Return on equity−9.9%–
Return on invested capital−72.5%−19.3% (better)
Financial health
Debt / equity0.00–
Interest coverage–−1.7×
Current ratio2.99 (better)0.48
Piotroski F-score56 (better)
Ownership
Held by institutions1.8%0.03%
Held by insiders19.0%0.83%
Insider net buying, 12 months$11.6M–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.